UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds

Heart (British Cardiac Society), 2022-04, Vol.108 (8), p.613

2022

Link zum Volltext

Verfügbarkeit prüfen

Drug-drug interactions between vitamin K antagonists and statins: a systematic review

European journal of clinical pharmacology, 2021-10, Vol.77 (10), p.1435-1441

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of dipeptidyl peptidase‐4 inhibitors and risk of splanchnic vein thrombosis: A Danish nationwide new‐user active comparator cohort study

Diabetes, obesity & metabolism, 2021-02, Vol.23 (2), p.648-652

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study

Therapeutic advances in gastroenterology, 2017-12, Vol.10 (12), p.919-929

2017

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban Plasma Levels and Levetiracetam

Annals of internal medicine, 2020-11, Vol.173 (9), p.771

2020

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban Plasma Levels and Levetiracetam

Annals of internal medicine, 2020-11, Vol.173 (9), p.771

Punia, Vineet

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants

Seminars in thrombosis and hemostasis, 2024-04, Vol.50 (3), p.489

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of Antithrombotic Drug Use With Subdural Hematoma Risk

JAMA : the journal of the American Medical Association, 2017-02, Vol.317 (8), p.836

2017

Link zum Volltext

Verfügbarkeit prüfen

Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants

Drug safety, 2018-07, Vol.41 (7), p.685-695

2018

Link zum Volltext

Verfügbarkeit prüfen

Interaction between warfarin and cannabis

Basic & clinical pharmacology & toxicology, 2019-01, Vol.124 (1), p.28-31

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-world experience with reversal of dabigatran by idarucizumab

Thrombosis research, 2021-01, Vol.197, p.179-184

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of Non‐Vitamin K Antagonist Oral Anticoagulants 2008–2016: A Danish Nationwide Cohort Study

Basic & clinical pharmacology & toxicology, 2018-10, Vol.123 (4), p.452-463

2018

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study

Clinical infectious diseases, 2021-12, Vol.73 (12), p.2283-2293

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study

Pharmacoepidemiology and drug safety, 2018-02, Vol.27 (2), p.174-181

2018

Link zum Volltext

Verfügbarkeit prüfen

Trends in Off‐Label Prescribing of Sedatives, Hypnotics and Antidepressants among Children and Adolescents – A Danish, Nationwide Register‐Based Study

Basic & clinical pharmacology & toxicology, 2017-04, Vol.120 (4), p.360-367

2017

Link zum Volltext

Verfügbarkeit prüfen

Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators

Journal of affective disorders, 2019-04, Vol.249, p.242-252

2019

Link zum Volltext

Verfügbarkeit prüfen

Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment

Expert review of hematology, 2021-04, Vol.14 (4), p.335-346

2021

Link zum Volltext

Verfügbarkeit prüfen

Odense Pharmacoepidemiological Database: A Review of Use and Content

Basic & clinical pharmacology & toxicology, 2017-05, Vol.120 (5), p.419-425

2017

Link zum Volltext

Verfügbarkeit prüfen

Cohort selection in register‐based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade‐off between selection bias and misclassification

Basic & clinical pharmacology & toxicology, 2020-07, Vol.127 (1), p.3-5

2020

Link zum Volltext

Verfügbarkeit prüfen

Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation

American journal of epidemiology, 2020-12, Vol.189 (12), p.1467-1477

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation

Europace (London, England), 2017-07, Vol.19 (7), p.1091-1095

2017

Link zum Volltext

Verfügbarkeit prüfen

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries

Europace (London, England), 2021-11, Vol.23 (11), p.1722-1730

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of international guideline recommendations for the diagnosis of pulmonary embolism

The Lancet. Haematology, 2023-11, Vol.10 (11), p.e922-e935

2023

Link zum Volltext

Verfügbarkeit prüfen

Antimycotic Treatment of Oral Candidiasis in Warfarin Users

The American journal of medicine, 2021-05, Vol.134 (5), p.e308-e312

2021

Link zum Volltext

Verfügbarkeit prüfen

Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin

Pharmacoepidemiology and drug safety, 2018-09, Vol.27 (9), p.1011-1018

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(37)
Pharmacology & Pharmacy
(20)
Female
(19)
Anticoagulants
(18)
Male
(16)
Aged
(15)
Aged, 80 And Over
(13)
Administration, Oral
(12)
Middle Aged
(12)
Toxicology
(12)
Risk Factors
(11)
Anticoagulants - Adverse Effects
(9)
Anticoagulants - Therapeutic Use
(9)
Atrial Fibrillation - Drug Therapy
(9)
Drug Interactions
(9)
Fibrillation
(8)
Pharmacoepidemiology
(8)
Public, Environmental & Occupational Health
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds

Drug-drug interactions between vitamin K antagonists and statins: a systematic review

Use of dipeptidyl peptidase‐4 inhibitors and risk of splanchnic vein thrombosis: A Danish nationwide new‐user active comparator cohort study

Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study

Rivaroxaban Plasma Levels and Levetiracetam

Rivaroxaban Plasma Levels and Levetiracetam

Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants

Association of Antithrombotic Drug Use With Subdural Hematoma Risk

Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants

Interaction between warfarin and cannabis

Real-world experience with reversal of dabigatran by idarucizumab

Use of Non‐Vitamin K Antagonist Oral Anticoagulants 2008–2016: A Danish Nationwide Cohort Study

Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study

Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study

Trends in Off‐Label Prescribing of Sedatives, Hypnotics and Antidepressants among Children and Adolescents – A Danish, Nationwide Register‐Based Study

Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators

Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment

Odense Pharmacoepidemiological Database: A Review of Use and Content

Cohort selection in register‐based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade‐off between selection bias and misclassification

Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries

Comparison of international guideline recommendations for the diagnosis of pulmonary embolism

Antimycotic Treatment of Oral Candidiasis in Warfarin Users

Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin

Suchergebnisse filtern